Primary mediastinal B-cell lymphoma

Hematological Oncology

Volumn 25, Issue 4, 2007, Pages 157-163

  Boleti, E ^a   Johnson, P W M ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

B cell lymphoma; Immunology; Mediastinum; Primary mediastinal B cell lymphoma; Treatment

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FLUORODEOXYGLUCOSE F 18; GALLIUM 67; PREDNISONE; RITUXIMAB; VINCRISTINE;

B CELL LYMPHOMA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL FEATURE; GENE EXPRESSION PROFILING; HUMAN; MEDIASTINUM TUMOR; NONHODGKIN LYMPHOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW;

CYTOGENETIC ANALYSIS; DISEASE MANAGEMENT; GENE EXPRESSION PROFILING; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, B-CELL; LYMPHOMA, LARGE B-CELL, DIFFUSE; MEDIASTINAL NEOPLASMS;

EID: 37649025338     PISSN: 02780232     EISSN: 10991069     Source Type: Journal    
DOI: 10.1002/hon.818     Document Type: Review

References (54)

1. Savage KJ, Shipp MA. Initial evaluation :staging and prognostic factors. In Non-Hodgkin's Lymphomas, Mauch PM, Armitage JO, Harris LN, Dalla-Favera R, Coiffier B (eds). Lippincott Williams and Wilkins: Philadelphia, PA, 2003.
2. The Non-Hodgkin's Lymphoma Pathologic Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood 1997; 89: 3909-3918.
3. Jaffe ES, Harris NL, Stein H, et al. World Health Organization classification of tumors. Pathology and genetics of tumors of hematopoietic and lymphoid tissues. IARC Press: Lyon, France, 2001.
4. Lichtenstein A, Levine A, Taylor C, et al. Primary mediastinal lymphoma in adults. Am J Med 1980; 68: 509-514.
5. Miller JB, Variakojis D, Bitran JD, et al. Diffuse histiocytic lymphoma with sclerosis: a clinicopathological entity frequently causing superior vena cava obstruction. Cancer 1981; 47: 748-756.
6. Trump DL, Mann RB. Diffuse large cell and undifferentiated lymphomas with prominent mediastinal involvement. Cancer 1982; 50: 277-282.
7. Waldron JA, Dohring EJ, Farber LR. Primary large cell lymphomas of the mediastinum: an analysis of 20 cases. Semin Diag Pathol 1985; 2: 281-295.
8. Hofmann WJ, Momburg F, Möller P. Thymic medullary cells expressing B lymphocyte antigens. Hum Pathol 1988; 19: 1280-1287.
9. Isaacson PG, Norton AJ, Addis BJ. The human thymus contains a novel population of B lymphocytes. Lancet 1987; 2: 1488-1491.
10. Addis BJ, Isaacson PG. Large cell lymphoma of the mediastinum: a B-cell tumour of probably thymic origin. Histopathology 1986; 10: 379-390.
11. Menestrina F, Chilosi M, Bonetti F, et al. Mediastinal large-cell lymphoma of B-type with sclerosis: histopathological and immunohistochemical study of eight cases. Histopathology 1986; 10: 589-600.
12. Möller P, Moldenhauer G, Momburg F, et al. Mediastinal lymphoma of clear cell type is a tumor corresponding to terminal steps of B cell differentiation. Blood 1987; 69: 1087-1092.
13. Paulli M, Sträter J, Gianelli U, et al. Mediastinal B-cell lymphoma: a study of its histomorphologic spectrum based on 109 cases. Hum Pathol 1999; 91: 4292-4299.
14. Möller P, Lämmler B, Eberlein-Gonska M, et al. Primary mediastinal clear cell lymphoma of B-cell type. Virchows Arch A Pathol Anat Histopathol 1986; 409: 79-92.
15. Abou-Elella AA, Weisenburger DD, Vose JM, et al. Primary mediastinal large B-cell lymphoma: a clinicopathologic study of 43 patients from the Nebraska lymphoma study group. J Clin Oncol 1999; 17: 784-790.
16. Rodriguez J, Pugh WC, Romaguera JE, et al. Primary mediastinal large cell lymphoma. Hematol Oncol 1994; 94: 175-192.
17. Scarpa A, Bonetti F, Menestrina F, et al. Mediastinal large-cell lymphoma with sclerosis. Genotypic analysis establishes its B nature. Virchows Arch A Pathol Anat Histopathol 1987; 412: 17-21.
18. Perrone T, Frizzera G, Rosai J. Mediastinal diffuse large-cell lymphoma with sclerosis. Am J Surg Pathol 1986; 10: 176-180.
19. Lamarre L, Jacobson JO, Aisenberg AC, et al. Primary large cell lymphoma of the mediastinum: a histologic and immunophenotypic study of 29 cases. Am J Surg Pathol 1989; 13: 730-737.
20. Kanavaros P, Gaulard P, Charlotte F, et al. Discordant expression of immunoglobulin and its associated molecule mb-1/CD79a is frequently found in mediastinal large B cell lymphomas. Am J Pathol 1995; 146: 735-741.
21. Falini B, Venturi S, Martelli M, et al. Mediastinal large B-cell lymphoma: clinical and immunohistological findings in 18 patients treated with different third generation regimens. Br J Haematol 1995; 89: 780-789.
22. Lazzarino M, Orlandi E, Paulli M, et al. Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: a multicenter study of 106 patients. J Clin Oncol 1997; 15: 1646-1651.
23. Eichelmann A, Koretz K, Mechtersheimer G, et al. Adhesion recepror profile of thymic B-cell lymphoma. Am J Pathol 1992; 141: 729-741.
24. Rosenwald A, Wright G, Leroy K, et al. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favourable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J Exp Med 2003; 198: 851-862.
25. Bea S, Zettl A, Wright G, et al. Diffuse large B-cell lymphoma subgroups have distinct genetic profile that influence tumor biology and improve gene-expression-based survival prediction. Blood 2005; 106: 3183-3190.
26. Copie-Bergman C, Gaulard P, Maouche-Chrétien L, et al. The MAL gene is expressed in primary mediastinal large B-cell lymphoma. Blood 1999; 94: 3567-3575.
27. Copie-Bergman C, Boulland M-L, Dehoulle C, et al. Interleukin 4-induced gene 1 is activated in primary mediastinal large B-cell lymphoma. Blood 2003; 101: 2756-2761.
28. Joos S, Otano-Joos MI, Ziegler S, et al. Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene. Blood 1996; 87: 1571-1578.
29. Melzner I, Bucur AJ, Bruderlein S, et al. Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line. Blood 2005; 105: 2535-2542.
30. Rigaud G, Moore PS, Taruscio D, et al. Alteration of chromosome arm 6p is characteristic of primary mediastinal B-cell lymphoma, as identified by genome-wide allelotyping. Genes Chromosomes Cancer 2001; 31: 191-195.
31. Bentz M, Barth TF, Brüderlein S, et al. Gain of chromosome arm 9p is characteristic of primary mediastinal b-cell lymphoma (MBL): comprehensive molecular cytogenetic analysis and presentation of a novel MBL cell line. Genes Chromosomes Cancer 2001; 30: 393-401.
32. Tsang P, Cesrman E, Chadburn A, et al. Molecular characterization of primary mediastinal B cell lymphoma. Am J Pathol 1996; 148: 2017-2024.
33. Savage KJ, Monti S, Kutok JL, et al. The molecular signature of mediastinal large cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood 2003; 102: 3871-3879.
34. Feuerhake F, Kutok JL, Monti S, et al. NfκB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes. Blood 2005; 106: 1392-1399.
35. Barth TFE, Leithäuser F, Joos S, et al. Mediastinal (thymic) large B-cell lymphoma: where do we stand? Lancet Oncol 2002; 3: 229-234.
36. Aisenberg AC. Primary large cell lymphoma of the mediastinum. Semin Oncol 1999; 26: 251-258.
37. Cazals-Hatem D, Lepage E, Brice P, et al. Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA ("Groupe d' Etudes des Lymphomes de l' Adulte") study. Am J Surg Pathol 1996; 20: 877-888.
38. Kirn D, Mauch P, Shaffer K, et al. Large-cell and immunoblastic lymphoma of the mediastinum: prognostic features and treatment outcome in 57 patients. J Clin Oncol 1993; 11: 1336-1343.
39. Lazzarino M, Orlandi E, Paulli M, et al. Primary mediastinal B-cell lymphoma with sclerosis: an aggressive tumor with distinctive clinical and pathologic features. J Clin Oncol 1993; 11: 2306-2313.
40. Todeschini G, Ambrosetti A, Meneghini G, et al. Mediastinal large B-cell lymphoma with sclerosis: a clinical study of 21 patients. J Clin Oncol 1990; 8: 804-808.
41. Depuydt P, Van Hoof A, Sellesdag D, et al. Mediastinal B-cell lymphoma with sclerosis: clinical features and treatment results in 10 patients. Acta Clin Belg 1995; 50: 137-143.
42. Bishop P, Wilson W, Pearson D, et al. CNS involvement in primary mediastinal large B-cell lymphoma. J Clin Oncol 1999; 17: 2479-2485.
43. Savage KJ, Al-Rajhi N, Voss N, et al. Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience. Ann Oncol 2006; 17: 123-130.
44. Zinzani PL, Martelli M, Magagnoli M, et al. Treatment and clinical management of primary mediastinal large B-cell lymphoma with sclerosis: MACOP-B regimen and mediastinal radiotherapy monitored by (67)gallium scan in 50 patients. Blood 1999; 94: 3289-3293.
45. Jacobson JO, Aisenberg AC, Lamarre L, et al. Mediastinal large cell lymphoma: an uncommon subset of adult lymphoma curable with combined modality therapy. Cancer 1988; 62: 1893-1898.
46. Todeschini G, Secchi S, Morra E, et al. Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B. Br J Cancer 2004; 90: 372-376.
47. van Besien K, Kelta M, Bahaguna R Primary mediastinal B-cell lymphoma: a review of pathology and management. J Clin Oncol 2001; 19: 1855-1864.
48. Jerusalem G, Beguin Y, Fassotte MF, et al. Whole-body positron emission tomography using 18F-fluorodeoxyglucose for post-treatment evaluation in Hodgkin's disease and non- Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging. Blood 1999; 94: 429-433.
49. Juweid ME, Wiseman GA, Vose JM, et al. Response assessment of aggressive non-Hodgkin's lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography. J Clin Oncol 2005; 23: 4652-4661.
50. Juweid ME, Cheson BD. Role of positron emission tomography in lymphoma. J Clin Oncol 2005; 23: 4577-4580.
51. Zinzani PL, Fanti S, Battista G, et al. Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients. Br J Cancer 2004; 91: 850-854.
52. Popat U, Przepiork D, Champlin R, et al. High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: mediastinal localization predicts for a favorable outcome. J Clin Oncol 1998; 16: 63-69.
53. Sehn LH, Antin JH, Shulman LN, et al. Primary diffuse large B-cell lymphoma of the mediastinum: outcome following high-dose chemotherapy and autologous hematopoietic cell transplantation. Blood 1998; 91: 717-723.
54. Jaffe ES, Muller-Hermelink K. Relationship between Hodgkin's disease and non-Hodgkin's lymphomas. In Hodgkin's Disease, Hoppe RT, Mauch PM, Armítage JO, Díehl V, Weíss LM (eds). Lippincott Williams & Wilkens: Philadelphia, PA, 2007, 181-191.